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Abstract
Background: The pathogenesis related protein PR10 (TcPR-10), obtained from the Theobroma cacao-Moniliophthora
perniciosa interaction library, presents antifungal activity against M. perniciosa and acts in vitro as a ribonuclease. However,
despite its biotechnological potential, the TcPR-10 has the P-loop motif similar to those of some allergenic proteins such as
Bet v 1 (Betula verrucosa) and Pru av 1 (Prunus avium). The insertion of mutations in this motif can produce proteins with
reduced allergenic power. The objective of the present work was to evaluate the allergenic potential of the wild type and
mutant recombinant TcPR-10 using bioinformatics tools and immunological assays.
Methodology/Principal Findings: Mutant substitutions (T10P, I30V, H45S) were inserted in the TcPR-10 gene by site-
directed mutagenesis, cloned into pET28a and expressed in Escherichia coli BL21(DE3) cells. Changes in molecular surface
caused by the mutant substitutions was evaluated by comparative protein modeling using the three-dimensional structure
of the major cherry allergen, Pru av 1 as a template. The immunological assays were carried out in 8–12 week old female
BALB/c mice. The mice were sensitized with the proteins (wild type and mutants) via subcutaneous and challenged
intranasal for induction of allergic airway inflammation.
Conclusions/Significance: We showed that the wild TcPR-10 protein has allergenic potential, whereas the insertion of
mutations produced proteins with reduced capacity of IgE production and cellular infiltration in the lungs. On the other
hand, in vitro assays show that the TcPR-10 mutants still present antifungal and ribonuclease activity against M. perniciosa
RNA. In conclusion, the mutant proteins present less allergenic potential than the wild TcPR-10, without the loss of
interesting biotechnological properties.
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Introduction
The development of genetically modified organisms (GMOs)
through molecular engineering techniques is an alternative to
plant genetic improvement programs for the purpose of promoting
resistance against pathogens, herbicides or environmental stresses
[1,2]. Among the genes that can be potentially used in the genetic
transformation of plants so as to improve resistance against
diseases, those coding for pathogenesis-related proteins stand out
(PR) [3,4,5,6,7]. According to the structural, enzymatic or
biological properties, PR proteins are classified into 17 families,
whereas PR 1, 2, 3, 4, 5, 8, 10 and 14 are reported to contain
proteins with homology to pollen or food allergens; this fact limits
the biotechnological application of these genes [8,9,10,11]. Among
the allergenic proteins classified as PR-10, the Bet v 1 isolated from
Betula verrucosa is the main allergen present in pollen grains [12,13].
Food allergens such as Pru p 1 from pear (Prunus persica) [14], Mal
d 1 from apple (Malus domestica) [15], Pru av 1 from cherry (P.avium)
[16,17] and Dau c 1 in carrot (Daucus carota) [18] are also reported
as part of the PR-10 family.
The PR-10 family is characterized by the presence of a highly
conserved region called P-loop motif, which is usually associated
with ribonuclease activity in some members of this family [19].
Yet, the presence of this domain is also associated with the
allergenicity of pollen grains [20,21]. The P-loop motif present in
some allergenic proteins such as Mal d 1 (Malus domestica) [22], Bet
v1( Betula verrucosa) [12] and Api g 1 (Apium graveolens) [23] is also
conserved in the TcPR-10 gene identified in a cDNA library
observed in the interaction between Theobroma cacao and
Moniliophthora perniciosa.
The TcPR-10 protein has a promising biotechnological
potential to act as a ribonuclease and presents antifungal activity
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e37969against M. perniciosa, the causal agent of witches’ broom disease,
which is one of the most devastating diseases of cocoa plants [24].
The overexpression of the TcPR10 gene may open new possibilities
for cocoa breeding. However, the development of genetically
modified organisms (GMOs) requires the discrimination of
allergenic and non-allergenic recombinant proteins and a predic-
tion of the potential cross-linking activity of the proteins of the
immune system [25,26]. The assessment of allergenicity potential
is a major procedure used to ensure the biosafety of GMOs [27].
Thus, this study has aimed to assess the allergenicity potential of
the antifungal protein TcPR-10 using bioinformatic tools and
immunological assays, and develop and test a mutant strain with
little or no allergenic ability, but that maintains ribonuclease and
antifungal activities.
Results
Identification of the Allergenicity Potential of TcPR-10
through Bioinformatics Analysis
The assessment of the allergenicity potential of the TcPR-10
protein by sequence comparison analysis with sequences of
allergens from the SDAP (Structural Database of Allergenic
Proteins) [28,29] database revealed similarity to 13 different
groups of allergens (Table 1). The TcPR-10 sequence shows
stretches of 6 continuous and identical amino acids with food
allergens like Rub i (red raspberry), Dau c 1.01 (carrot), Act d 8
(kiwi fruit), Api g 1 (celery), Mad 1 (apple), Pru ar 1 (apricot),
Cor a 1.04 (hazelnut), Pru p 1 (peach), Pru av 1 (sweet cherry),
and also pollen allergens such as Que a 1 (white oak) and Bet v 1
(white birch). Based on the sequence of continuous amino acids,
one should note that the TcPR-10 gene showed similarity to
allergenic proteins especially in the region rich in glycine (P-loop
motif 47GDGGVGSIK55) (Figure 1). Despite the fact that the P-
loop motif of the TcPR-10 protein is not identical to Pru p 1,
Pru av 1, Bet v 1, Que a 1 and Cor a 1, these proteins also have
a P-loop and there are amino acid sequence variations among
glycine residues. At position 48, the Bet v 1, Que a 1 and Cor a
1 sequences contain asparagine residues, whereas the TcPR-10
protein contains aspartic acid residues. At position 51, the Pru p
1, Pru av 1, Bet v 1, Que a 1 and Cor a 1 proteins show a
proline residue, whereas TcPR-10 shows a valine residue. In
addition to the P-loop domain, theTcPR-10 protein sequence
shows the common 129EEEIKAGK136 region with Bet v 1, Cor
a 1 and Act d 8, the common 116TSHYHT121 region with Mal
d 1, Pru ar 1, Pru p 1.0101 and Pru av 1, the 26DSDNLI31
region only with Que a 1, and 59FPEGSHFKY67, only with Bet
v 1 (Figure 1).
Based on the identity parameter greater than 35% in a window
of 80 amino acids, the TcPR-10 sequence has an excess of 50%
homology with the Mad 1, Pru ar 1, Pru p 1.0101, Bet v 1 Cor a
1.0403 and Cor a 1.0402 sequences. The percentage similarity for
these six allergen sequences is consistent with the PD value under
14, thus indicating similarity between the physicochemical
properties of such allergens and TcPR-10. It can be noted that
the lowest and therefore most significant overall similarity index
values (E-value) are also observed for these allergen sequences. E-
value and PD indexes indicate that TcPR-10 and PD show
similarity to pollen and food allergens (Table 1).
Changes in the Structure of the Hydrophobic Cavity and
the Surface of TcPR-10
In order to select sites for insertion of mutations that reduce or
eliminate the possible allergenic potential of TcPR-10 shown by
bioinformatics analysis using SDAP, molecular modeling has been
employed so as to predict changes and determine the implications
that they may cause in the tridimensional structure of TcPR-10.
The templates were identified by PSI-Blast [30] analyses against
protein data banking-PDB [31]. The sequences of wild and
mutant-type TcPR-10 showed 51% identity in relation to the
templates Pru av 1 (pdb: 1e09_A) and RMSD of 0.345 and 0.351,
respectively (Table 2). Identity above 50% and an E-value below
4e
243 indicate that the crystal structure of Pru av 1 is a good
model to be used as a template. The value of RMSD indicates that
there was little difference between models and template structures.
The models of wild and mutant-type TcPR-10 showed three
alpha-helices: a1 (16–26); a2 (89–91); a3 (129–152); six stranded
anti-parallel beta-sheets (b1-b6): b1 (3–12); b2 (40–46); b3 (54–58);
b4 (80–85); b5 (96–106); b6 (111–121); and 9 loop L1 (13–15); L2
(27–39); L3 (47–53); L4 (59–79); L5 (86–88); L6 (92–95); L7 (107–
110); L8 (122–128); L9 (153–158) (Figure 2A).
The stereochemical parameters of the model protein structural
wild type and mutant were analyzed using the Procheck
(Laskowski et al., 2005) and Anolea softwares (Melo; Feytmans,
1998). The Ramachandran plot showed that 76,1% and 76,6% of
residues in most favored regions for wild and mutant-type TcPR-
10, respectively. 21,7% and 21,2% of residues in additional
allowed regions and only 2,2% and 2,2% residues in disallowed
regions for wild and mutant-type TcPR-10, respectively. Analysis
of the stereochemical properties with Procheck 3.4 confirms good
stereochemical quality of the structure ensemble as mirrored by
the fact that more than 97% of the amino acid residues are located
in the most favoured regions of the Ramachandran plot.
Cloning and Expression of TcPR-10
The recombinant plasmid pET28a containing the TcPR-10
insert with the T10P, I30V and H45S substitutions was cloned and
expressed in E. coli BL21 (DE3) under the control of the T7
promoter. The three points of substitutions T10P, I30V and
H45S-10 inserted into TcPR-10 were marked underlined in the
alignment (Figure 1). The heterologous expression of the protein
was confirmed in 15% SDS-PAGE gel stained with Coomassie
Brilliant Blue and the expression of peptides of an approximate
molecular mass of 19KDa fused to the histidine residues, was
observed (His-Tag). The purification of the wild and mutant-type
TcPR-10 was confirmed by visualization of single bands on SDS-
PAGE gel (Figure 3).
Ribonuclease and Antifungal Activity of the mutanttcpr-
10
The verification of possible changes in the catalytic function
of the TcPR-10 protein due to the insertion of nucleotide
substitutions was performed in vitro, using RNA from M.
perniciosa. Incubation of the mutant TcPR-10 protein with RNA
from M. perniciosa at 25uC at different times shows that,
although there has been a slight decrease in the degradation
rate, the insertions have not altered the activity of the
ribonuclease protein. After 10 minutes of incubation with the
TcPR-10 mutant gene, the RNA was not completely degraded,
as observed for the wild-type TcPR-10 (Figure 4, line 4). After
one hour, the RNA bands incubated with the mutant TcPR-10
were still present, but after 3 hours, the RNA from M. perniciosa
was observed to be totally degraded both in the wild-type and
the mutant protein (Figure 4, row 6).
The in vitro effect of the TcPR-10 mutant protein in the survival
of M. perniciosa shows that changes do not inhibit the antifungal
activity of the protein. The survival of the fungus decreases as the
concentration of mutant TcPR-10 increases, showing the same
profile observed for the wild protein (Figure 5). At a concentration
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e37969of 8 mg/mL, the wild TcPR-10 protein shows a 73% inhibition
rate of growth for the fungus, and 61% for the mutant TcPR-10
protein, with no statistical difference between values (p.0.05;Tu-
key’s test). Despite the fact that the wild-type protein shows a
higher percentage of inhibition as compared with the mutant
protein especially when the concentration increases to 10 mg/mL,
Figure 1. Amino acid sequence alignment of TcPR-10 with the allergens from the SDAP database (http://align.genome.jp/sit-bin/
clustalw). The three point mutations for TcPR-10 (T10P, I30V, H45S) are marked in sequence alignment and P-loop was underlined. The identical,
highly conserved, and conserved amino acids among the sequences are denoted with (*), (:), and (.), respectively. Matching regions of contiguous
amino acids are highlighted in black.
doi:10.1371/journal.pone.0037969.g001
Table 2. Template obtained by PSI-Blast algorithm for modeling of proteins structures TcPR-10 wild and mutant.
Template Identify % E-value Organism RMSD(A ˚) Reference
TcPR-10 wild 1e09.pdb 51 4e
243 Prunus avium 0.345 Neudecker et al., 2001
TcPR-10 Mutant 1e09.pdb 51 2e
242 Prunus avium 0.351 Neudecker et al., 2001
doi:10.1371/journal.pone.0037969.t002
Allergenicity Potential of TcPR-10 Protein
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e37969reducing the growth of the fungus by 91% - the mutant protein
only reduces 56% - these values have not statistically differed
(p.0.05, Tukey’s test).
Immunological Response to TcPR-10
The production of immunoglobulin E (IgE) stimulated by an
allergen usually triggers the typical symptoms of hypersensitivity
Figure 2. Three-dimensional structure of TcPR-10 obtained by homology modeling with Pru av1 (Protein Data Bank, 1e09_A) as
template using SWISS-MODEL. A. The secondary structure elements are colored: alpha-helices in red, anti-parallel beta-sheets in yellow and P-
loops in green. B. Molecular surface of TcPR-10 wild with matching regions of contiguous amino acids: 47GDGGVG52 in blue; 59FPEGSHFKY67 in
brown; 116TSHYHT121 in gray; 129EEEIKAGK136 in peach. C e E Molecular surface of TcPR-10 wild type with amino acids for mutations highlighted in
orangen (Thr10, Ile30, His45). DeF .TcPR-10 mutant type with point mutations in blue (Pro10, Val30, Ser45).
doi:10.1371/journal.pone.0037969.g002
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10 on airway inflammation, the IgE levels in serum and infiltration
of inflammatory leukocytes in the lung have been examined. IgE
levels in serum of animals challenged with the wild TcPR-10
protein has increased by 40% (M: 3.02; SD: +0.16) as compared to
control animals (M: 1.8; SD: +0.32) (p,0.001; Tukey’s test)
(Figure 6A). On the other hand, those treated with mutant TcPR-
10 have only increased by 17% (M: 2.18; SD: +0.34) (p.0.05;
Tukey’s Test) as compared to the control (Figure 6A). The IgE
levels in animals treated with mutant protein is about 27% lower
as compared with animals that received the wild-type TcPR-10,
accordingly supporting the hypothesis that the insertion of
mutations in TcPR-10 can reduce the allergenicability of this
protein. The infiltration of inflammatory leukocytes was investi-
gated by the following parameters: (i) total cell count in the BAL
bronchoalveolar lavage fluid and (ii) analysis of histological
sections. The total number of cells in BAL from animals treated
with wild TcPR-10 protein (M: 12.956104; D:+1.826104) was
higher than that present in the mutant and control groups, hence
indicating increases of 62% (4.96104+1.086104) and 57% (M:
5.626104; D: +1.816104) (p,0.001, Tukey’s test), respectively
(Figure 6B).When comparing the mutant TcPR-10 protein with
the control group, there was no significant difference but a 12.81%
increase (p.0.05; Tukey’s test). The histological analysis of lungs
of mice treated with the wild-type TcPR-10 protein shows discrete
cellular infiltrate in the peribronchiolar region and mild desqua-
mation of the epithelium, with presence of mucus in the lumen of
the bronchi (Figure 6D). These changes were not seen in the lungs
of mice treated with the mutant protein (Figure 4E) and neither in
the control animals (Figure 6C).
Discussion
The pathogenesis-related proteins (PR) involved in plant
defense response against pathogens - including PR class 10 - are
reported to be constitutively expressed in pollen, fruits and
vegetables and may cause allergic reactions in humans [32,33,34].
The ribonuclease and antifungal activities of the heterologous
protein TcPR-10 makes it important to the defense of T. cacao
against M. perniciosa. This fact suggests that the TcPR-10 gene can
be used to increase the resistance of plants to pathogens [24] and is
therefore subject of considerable biotechnological interest. Yet,
despite the importance of biotechnology, the allergenicity potential
of TcPR-10 had not been previously reported.
The identification of the allergenicity potential of proteins is
usually conducted using bioinformatics tools and immunological
assays [26,35,36]. In conjunction with the Food and Agriculture
Organization of the United Nations [37], the World Health
Organization has recommended two criteria using bioinformatics
analysis to identify the allergenic potential of proteins, both based
on sequence alignments: one that indicates identity greater than
35% in a window of 80 amino acids and another with 6
continuous amino acids between the sequence examined and those
available in the databases and already reported to induce IgE
production [38,39,40,41].
According to these parameters, the TcPR10 sequence showed
similarity with thirteen allergenic sequences, and the region rich in
glycine (P-loop motif 47GXGGXGXXK55) was highly conserved
in all sequences (Table 1). Among the allergens that showed
similarity with TcPR-10, Dau c 1, Pet c PR10, Tar o RAP, Api g
1, Mal d 1, Pruar 1, Pruav 1, Bet v 1 Cora 1 are reported as
belonging to the family of pathogenesis-related proteins 10 - Bet v
1 (PF00407) [26]. The analysis of X-ray diffraction of protein Bet v
1 has identified several regions responsible for intermolecular
contacts with the monoclonal Fab fragment of the IgG1 molecule
(BV16), the region 42ENIEGNGGPGT52 (corresponding to the
P-loop) identified as the main binding epitope [20]. Other sites of
contact have been identified: R70, D72, H76, I86, E87 and K97
[20]. The TcPR-10 protein has the same amino acid residues at
positions 72, 86 and 87, located near the conserved region
59FPEGSHFKY67, thus suggesting that these regions may act as
binding sites for IgE. The crystalized structure of the Bet v 1-BV16
Fab complex demonstrated that the epitope formed by these
amino acids, is clearly conformational [21], however, it is
interesting to notice that the P-loop region is also a sequential
Figure 3. SDS-PAGE (15%) analysis of recombinants TcPR-10
Wild Types (wt) and Mutant (mut) proteins expressed in E. coli
BL21(DE3). 1– Soluble fraction TcPR-10 mut; 2– Insoluble fraction
TcPR10 mut; 3– Soluble fraction TcPR-10 wt; 4– Insoluble fraction
TcPR10 wt; 5 - pET28a-TcPR-10 mut without induction; 6 - pET28a-TcPR-
10 mut after induction; 7 - pET28a-TcPR-10 wt without induction; 8 -
pET28a-TcPR-10 mut 3 h after induction; M- Protein molecular weight
markers.
doi:10.1371/journal.pone.0037969.g003
Figure 4. Ribonuclease activity of recombinant TcPR-10 Wild Types (wt) and Mutant visualized in 1% agarose gel. 1 mg RNA from M.
perniciosa was incubated with 1 mg of recombinats proteins at 256C at different times. Lane 1. RNA without protein; Lane 2. RNA with
boiled TcPR10 mut 2 h incubation; Lane 3. RNA with boiled TcPR10 wt 2 h incubation; Lane 4, 6, 8, 10 and 12 RNA incubated with TcPR10 mut by
10 min, 20 min, 1 h, 2 h and 3 h, respectively; Lane 5, 7, 9, 11 and 13 RNA incubated with TcPR10 wt by 10 min 20 min, 1 h, 2 h and 3 h,
respectively. Arrows indicate RNA bands without degradation.
doi:10.1371/journal.pone.0037969.g004
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the epitope also in the ligation of IgE to Bet v 1. Mutations in the
E45 residue, located in the middle of the BV16 epitope, was
defined as the dominant epitope in the ligation of IgE in the serum
of patients allergic to birch [21]. The residue of the amino acid 45,
although not conserved in TcPR-10 (His-45), also is localized
structurally in the superficial area which covers the location of the
P-loop. In Pru av 1, the mutation in the E45W amino acid, also
located in the P-loop region, does not alter the tertiary structure of
the protein, but alters the biophysical properties of the lateral
chain, and also reducing significantly the capacity of ligation to
IgE for Pru av a in the serum of patients allergic to cherry [42]. In
Figure 5. Survival of M. perniciosa dikaryotic broken hyphae incubated with different TcPR-10 wild and mutant type protein
concentrations (4, 8 and 10 mg/ml).
doi:10.1371/journal.pone.0037969.g005
Figure 6. Quantification of polyclonal IgE, BAL total cell count and histological illustration of the lung of BALB/c mice. A.
Quantification of polyclonal IgE antibody levels in serum of BALB/c mice. B. Cell counting in BAL fluid. The set average values per se quantification of
antibodies and showed normal (p,0,05; Shapiro Wilk Test) using the comparison test of means the parametric Tukey Test (a=0,05). *Significantly
high values compared to control. **Significantly reduced values compared to TcPR-10 wt. Horizontal bars represent the mean value of each group. C.
Lung were removed twenty-four hours after the last challenge. Lung tissue was fixed, embedded, cut into slices and stained with hematoxylin e eosin
(H&E) solution. C: Sections from control; D: wild TcPR-10; E: mutant TcPR-10.
doi:10.1371/journal.pone.0037969.g006
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had a significant contribution as to the ligation to IgE [21].
Residue 28 is also considered in Pru av 1 as a second region of the
IgE epitope [42].
Conserved areas of the molecular surface are listed as probable
IgE-binding epitopes [16]. The modeling of TcPR-10 protein
shows that the conserved regions with allergens in SDAP
59FPEGSHFKY67, 116TSHYHT121 and 129EEEIKAGK136
are located near the hydrophobic cavity (Figure 2B); it is relevant
to speculate whether these conserved areas indeed represent the
IgE binding epitopes. The internal cavity present in the PR-10
protein is reported as a binding site or reservoir for hydrophobic
ligands in the aqueous environment of the cell [3,12,43]. The
location of these conserved regions close to the cavity enables one
to underscore the importance of the cavity for the biological
function of PR-10 proteins. Furthermore, this is a possible
indicator of the location of epitopes binding to IgE; a fact that
may hinder the application of TcPR-10 gene in cocoa breeding.
The determination of three-dimensional structures of allergenic
proteins allows to identify amino acids exposed on the molecular
surface and that can act as IgE-binding epitopes [20]. Studies of
structure analysis suggest the presence of common regions between
Bet v 1, allergens, pollens, food, and PR proteins, therefore
allowing the use of molecular modeling to predict protein
structures. Using the SWISS-MODEL, the secondary structure
of the protein TcPR-10 (Figure 2A) indicates a pattern similar to
Bet v 1 and Pru av 1, differing by the presence of six b-sheets in
TcPR-10 [12,44]. The TcPR-10 protein has high homology with
pollen and food allergens showing possible IgE-binding epitopes
(Table 1) - as Bet v 1 and Pru av 1, respectively - for those
parameters, two questions are of great importance respecting the
parameters analyzed: 1) Is TcPR10 capable of triggering IgE-
dependent hypersensitivity? Is there a possible expression of a
mutant from the TcPR10 protein that maintains antifungal and
ribonuclease activities and reduces or eliminates the potential for
IgE production? The modeling of TcPR-10 protein has allowed to
select Thr10, Ile30 and His45 sites for insertion of mutations. The
amino acid Thr10 in TcPR-10 belongs to the b1 chain (3–12)
located on the exposed surface of the protein (Figure 2A and C) is
not situated near the conserved areas identified via SDAP. In turn,
the amino acid Ile30 located in loop L2 (27–39) is situated in the
cavity of the protein and near the conserved region 25DSDNLI30.
The T10P and I30V substitutions inserted in TcPR-10 have been
demonstrated in other PR-10 proteins - as an example, Bet v 1
[45] e Mal d 1 [22] - and are involved in the formation of IgE
epitopes. The substitution of histidine for serine at position 45,
located on b2 (40–46), was introduced for it precedes the
conserved region of P-loop 47GDGGVG52 from TcPR-10. In
Bet v 1, the residue from glutamic acid (E) at position 45 is
considered as crucial for the recognition of antibodies [20,21].
Analysis of the influence of site-directed mutations regarding the
IgE binding capacity has demonstrated that the P-loop is not
always involved in IgE binding and that similar amino acid
substitutions in proteins with high identity not always result in loss
of IgE binding capacity [22,23,46,47]. In Mal d 1, a single point
mutation at position 111 replacing serine for proline was
responsible for reducing allergenicity [48]. The ability of TcPR-
10 wt and TcPR-10 mut proteins to modulate the production
response of IgE was examined in a urine model. The elevation of
serum IgE levels in animals subjected to systemic sensitization by
subcutaneous injection followed by exposure of the airways to the
wild TcPR-10 indicate that this protein can modulate the response
of total IgE. In line with the high levels of IgE antibodies, the
number of leukocytes present in the BAL fluid was also higher in
the wild-type TcPR-10 experimental group (Figures 6A and B),
thus indicating the potential of TcPR10 in recruiting inflammatory
cells, especially polymorph nuclear cells (Figure 6D). Histological
analysis of lung tissue has confirmed the presence of cellular
infiltration detected in BAL fluid samples (Figure 6D). On the
other hand, there was a more attenuated inflammatory response in
mice challenged with the TcPR-10 mutant protein characterized
by lower levels of IgE and total leukocytes present in BAL fluid
(Figure 6E).
Interestingly, the insertion of mutations has not altered the
characteristics of ribonuclease and antifungal activity of the TcPR-
10 protein, which are crucial in the resistance of T. cacao; hence,
the method of insertion is of interest in the genetic improvement of
these plants. In AhPR10, isolated protein from Arachis hypogaea,
mutations in the K54N residue of the P-loop region has led to
complete loss of ribonuclease activity, while other points of
substitutions such as F148S and H150Q have partially affected the
catalytic activity, thus indicating that these residues are important
for the RNase function of this protein [19]. The maintenance of
catalytic activity in mutant TcPR-10 (Figure 4) suggests that the
amino acids Thr10, Ile30 and His45 may not determine this
function in protein, but influences the allergenic character, as
observed in the modulation of IgE production and recruitment of
inflammatory cells. Some authors suggest that ribonuclease is
associated with the capacity to inhibit fungal growth [19,49]. The
TcPR-10 mutant protein shows a small reduction in the time of
degradation of RNA and also presents a reduction in the ability to
inhibit fungal growth at a concentration of 10 mg/ml, as compared
with the wild-type TcPR-10, thus indicating that these activities
could be correlated. The presence of P-loop is also associated with
the ribonuclease of PR-10 proteins. Site-directed mutations in
three conserved amino acids (E95A, E147A, Y150A) and the
construction of deletions in the P-loop protein SPE-16 isolated
from Pachyrrhizus erosus seeds and classified as a member of the
family PR-10 has shown different changes in ribonuclease activity
[50]. In TcPR-10, the presence of conserved amino acid residues
E97, E149 and Y151 is associated with ribonuclease activity [24].
The constitutive expression of genes in transgenic plants is the
major concern about the allergenic potential of PR proteins.
Sowoboda et al (1995) [51] emphasize that the conditions of
pathogenic infections and stress can increase the level of
expression of proteins homologous to Bet v 1 in pollens and other
plant parts and thereby contribute to a significant increase in the
incidence of type 1 hypersensitivity detected over the last years in
industrialized countries. The overexpression of the TcPR-10 gene
in cocoa fruit should not be a critical factor limiting the genetic
improvement of this species by transgenic techniques, since the
processing of cocoa beans for chocolate production could reduce
the possible allergenic activity of this protein. In addition, there are
few reports of cases of clinical sensitivity to chocolate, what can be
explained by the changes that proteins undergo as a result of the
processing of cocoa beans [52]. Yet, the introduction of new forms
of chocolate that are less processed, such as pieces of raw or
toasted cocoa bean is a worrying concern, considering that the
allergenicity and the importance of cross-reactivity of these
products with other food allergens is unknown [53]. The possibility
of a constitutive expression of the TcPR-10 protein in transgenic
plants can become a public health problem, since the protein is
expressed in pollen grains and could become a potential source of
allergens triggering airway hypersensitivity, or the protein could
show cross-reactivity with food allergens.
The experimental evidences generated from this study pave the
way for the continuous use of the TcPR-10 protein as a potential
antifungal agent that can be used in cocoa breeding through
Allergenicity Potential of TcPR-10 Protein
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nuclease activity, the mutant TcPR-10 protein possibly modulates
the immune response, showing characteristics that can be
exploited in view of future applications in immunotherapies.
Materials and Methods
TcPR-10 Sequence
The TcPR-10 gene (accession number ES439858) used in this
study was identified from a cDNA library of cacao (cv. Catongo)
inoculated by M. perniciosa [54]. Open reading frame (ORF)
analysis of the nucleotide sequence obtained from the interaction
cDNA library followed by homology search on BLAST [30]
against sequences in the National Center for Biotechnology
Information database identified a putative PR-10 gene (insert size
of 779 bp) with an ORF of 480 nucleotides encoding a protein of
159 amino acid residues. The TcPR-10 gene was cloned into the
pET28a (Novagen) expression vector as previously described [24].
Identification of Potential Allergenic TcPR-10 Proteins
through Bioinformatics Analysis
The analysis of the potential allergenicity of the amino acid
sequence of the TcPR-10 protein was done using Bioinformatics
tools available in Structural Database of Allergenic Proteins
(SDAP, http://fermi.utmb.edu/SDAP). The sequence of TcPR-
10 underwent alignments based on identity more than 35% in the
window of 80 amino acids and identity of six contiguous amino
acids of the TcPR-10 protein in a known allergen available in Base
SDAP. The similarity of TcPR-10 with sequence available in the
SDAP allergens was done using the statistical E-value and the
property distance index PD. A low E-value (e.g. less than 10
26)
indicates a high significance of the sequence match. The index PD
values measure the similarity of two peptides based on five amino
acid descriptors E1–E5 that were determined by a multidimen-
sional scaling of 237 physicochemical properties of amino acids
[55].
PD(A,B)~
1
N
X N
i~1
X 5
j~1
lj Ej Ai{Ej(Bi)
      2
"# 1=2
:
Where: lj is the eigenvalue of the j-th E component, Ej(Ai) is the Ej
value for the amino acid in the i-th position from sequence A, and
Ej(Bi) is the Ej value for the amino acid in the i-th position from
sequence B.
Molecular Modeling
Comparative protein modeling was used to predict a structural
model of TcPR-10 protein implemented by Swiss Pdb-Viewer
v.3.7 accessible via the Expasy web Server (http://swissmodel.
expasy.org/) [31,56]. The homology modeling of protein TcPR-
10 was performed using as a template the three-dimensional
structure of the major cherry allergen, Pru av 1 (pdb:1e09_A), in
solution, resolved by heteronuclear multidimensional NMR
spectroscopy [17]. The modeling procedure started with the
choice of the template based on the alignment of the sequences of
proteins TcPR-10 wild and mutant to be modeled using the PSI-
BLAST [30] with known three-dimensional (3-D) proteins
structures available in the Protein Data BankProtein (pdb)
(http://www.pdb.org). After align primary target sequence with
template was submitted to modeling request to the Swiss Model
Server.
Validation of the secondary structure was performed using
PsiPred (Protein struture prediction Server - http://bioinf.cs.ucl.
ac.uk/psipred/) [57]. The stereochemical quality of structural
models of TcPR-10 wild type and mutant proteins obtained by
homology modeling with the protein structure Pru av 1
(SolutionNMR) was assessed using the programs PROCHECK
3.4 [58] and ANOLEA (Atomic Non-Local Environment
Assessment) [59]. The Root Mean Square Deviation (RMSD)
differences from ideal geometries for bond lengths and bond
angles were calculated on Pymol 3.0.
Site-directed Mutagenesis
TcPR-10 inserted into the pET28a expression vector was
modified by site-directed mutagenesis by overlap-extension based
on polymerase chain reaction (PCR). Three oligonucleotide
primer sets were constructed by site directed mutagenesis
(Thr10Pro, Ile30Val, His45Ser) (Table 3). The PCR amplification
was done at an annealing temperature of 50uC for 40 cycles of
polymerization using Taq polymerase (Taq High Fidelity-Fermen-
tas). The PCR product were digested with NdeI and SalI and
subcloned in expression vector pET28a (Novagen). The plasmid
pET28a with TcPR-10 insert were transformed into Escherichia coli
BL21(DE3) for protein expression. In the following TcPR-10
inserted into the pET28a without modification will be referred to
as TcPR-10 wild type (TcPR-10 wt) and engineered mutant as
TcPR-10 mutant (TcPR-10 mut).
Expression and Purification of Recombinants Wild and
Mutant-type TcPR-10
The expression of recombinant proteins TcPR-10 wt and
TcPR-10 mut was obtained by the induction of a colony
transformant grown in LB medium (Luria-Bertani) containing
Kanamycin (50 mg.mL
21) and Chloramphenicol (34 mg.mL
21)
under constant shaking at 37uC until reaching an OD600 between
0.5 and 0.7. Expression of recombinant proteins was induced by
1m M Isopropyl-ß- -thio-galactoside (IPTG) followed by 15 h
incubation at 18uC. The cells were centrifuged (110006g,
20 min, 4uC) and pellets suspended in lyses buffer (50 mM
phosphate buffer [PB], 300 mM NaCl, 2% of Nonidet, lysozyme
at 0.1 mg.mL
21, pH 7.4) and sonicated by 4 min (30 s pulse/min,
75% output) (Gex Ultrasonic processor 130, 130 W). Subsequently,
after centrifuged (110006g, 20 minutos, 4uC) the samples were
purified with TALONH Metal Affinity Resins (Clontech Laboratories)
according to the manufacturer’s instructions. Expression of
recombinant proteins was induced and harvested as described
previously [24]. Expression and purification of recombinants
TcPR-10 wt and TcPR-10 mut were analyzed by 15% Sodium
Table 3. Primer sets used for mutation at positions Thr10Pro,
Ile30Val and His45Ser in the TcPR-10 gene.
Primers Sequence (59 to 39) Nucleotides
T10P Forward CAA GAG TTC CCC TGC TCA GTT G 22–43
Reverse C AAC TGA GCA GGG GAA CTC TTG
I30V Forward C GAC AAC CTT GTC CCC AAA CTC 81–102
Reverse GAG TTT GGG GAC AAG GTT GTC G
H45S Forward G GAG TTG ATT AGT GGA GAT GG 126–146
Reverse CC ATC TCC ACT AAT CAC CTC C
The mutated codon is underlined and nucleotide substitution in bold.
doi:10.1371/journal.pone.0037969.t003
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Protein concentrations were determined by Bradford protein assay
[60].
Ribonuclease and Antifungal Activity of Mutant-type
TcPR-10
Ribonuclease and antifungal activity of TcPR-10 mut was
verified according to Bantignies and associates (2000) [61] with
suggested modifications by Pungartnik and associates (2009). The
RNA from M. perniciosa (Cp 553CEPLAC), growing in complete
medium CPD (2% glucose, 2% peptone, 2% agar added for solid
media), was extracted using phenol–chloroform method followed
by ethanol precipitation and analyzed by 1% agarose gel
electrophoresis. One microgram of RNA was incubated with
TcPR-10 mutant protein (1 mg) at 25uC at different times (10 min,
20 min, 1 h, 2 h and 3 h). Positive control used wild-type TcPR-
10 previously characterized with ribonuclease activity. Ribonucle-
ase activity was determined by degradation total of RNA observed
in 1% agarose gel. Antifungal activities of TcPR-10 mut protein
were determined by inhibiting growth of dikaryotic M. perniciosa
broken hyphae in increasing concentrations of the recombinant
protein (0, 4, 8 e 10 mg/plate) [62].
Allergen Sensitization and Challenge with Wild and
Mutant-type TcPR-10
Female BALB/c mice, 8–10 weeks old, obtained from the
Centro de Bioterismo (CEBIO) do Instituto de Cie ˆncias Biolo ´gicas
da Universidade Federal de Minas Gerais, Brasil (UFMG) were
used in this experiment. The animals were kept under conven-
tionally standard housed conditions of the Instituto de Cie ˆncias
Biolo ´gicas (ICB) of UFMG. This study, under the supervision of
Dr. Abelmon da Silva Gesteira, was specifically approved by the
Ethics Committee in Animal Experimentation (CEUA) of the
Universidade Estadual de Santa Cruz (UESC) under protocol
n. 001/09.
BALB/c mice were sensitized via subcutaneous (SC) in three
time periods 0, 14 and 28 days, with the proteins and 1 mg
Al(OH)3. For induction of allergic airway inflammation mice were
challenged intranasal (IN) at 35 and 36 days as shown in Figure 7.
The experiments were carried out in three experimental groups
(n=5): (i) 10 mg of TcPR10 wild protein [0.8 mg/mL], (ii) 10 mgo f
mutant [0.8 mg/mL] and (iii) control (PB, 300 mM NaCl).
Measurement of Total IgE
Mice were bled after 24 h of the last IN challenge to antibody
detection IgE by Enzyme-Linked Immunosorbent Assay (ELISA).
Blood samples were centrifuged (50006g, 10 min, 4uC) and serum
was collected. Plates were coated with a rat anti-mouse IgE
antibodies (UNLB) diluted in Coating Buffer (pH 9.6) (1:250).
Plates were incubated overnight in cold chamber at 4uC.
Afterwards they were washed with PBS. The coated wells were
blocked with PBS-Casein (50 mM phosphate buffer pH 7.2 with
0.25% of casein) for 1 h at room temperature. Detection of IgE
was carried out using biotinylated rat antimouse IgE (1:500)
incubated for 1 h at room temperature. Streptavidin-peroxidase
(Sigma-Aldrich) was used as a second-step reagent, developed
using H2O2 with Ortho-Phenylenediamine (OPD) solved in citrate
buffer, pH 5 (4 mg de OPD com 2 mLd eH 2O2 a 30%). The
reaction was blocked by adding sulfuric acid 2N. The reactions
were read on microplates BioRad Model 450 at 492 nm.
Bronchoalveolar Lavage and Pulmonary Histopathology
For the determination of cellular infiltration in the lung,
bronchoalveolar lavage fluids, were collected. After the sacrifice,
lungs were washed with 1 mL of cold PBS containing bovine
serum albumin (0.03%). Total number of cells was determined by
counting in a Neubauer chamber. The count was done by two
independent investigators under the optic microscope (OLYM-
PUS B12).
After the collection of the bronchoalveolar lavage the lungs were
removed and fixed with 10% buffered formaldehyde (v/v) (0.1 M
phosphate buffer, pH 7.4) and processed in a standard manner.
For the histological examination, fixed embedded lungs were
sectioned into 5 mm sections, deparaffinized with xylene and
graded ethanol and stained with haematoxylin and eosin (H&E).
For the morphological evaluation of lung tissues the preparations
were carried out microscopically (OLYMPUS B12) and images
captured in digital camera for evaluation of the symptons of the
airway inflammation as expression of infiltration of inflammatory
cells.
Statistical Analysis
Data were subjected to the Shapiro Wilk normality test followed
by analysis of variance for parametric data with Tukey Test
(a=0.05) to compare the means of experimental groups with
control. For nonparametric data the Kruskal-Wallis test was used.
Data are shown as mean (M) and standard deviation (SD).
Differences were considered significant for p values ,0,05.
Analyses were carried out using the Bioestat v4.0 [63] and
GraphPad PRISM v.4.0 [64].
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